Recent article should have a positive impact on all MJ stocks:
SPONSORED ARTICLE
Billionaire Investors Backing A Marijuana Boom In 2017
By James Burgess - Jul 16, 2017, 6:30 PM CDT
The biggest multi-decade opportunity for investors right now is the Canadian government’s legislation to legalize recreational marijuana by this time next year—and the first companies to win government approval will the high-risers.
In a sector that’s already seen stocks bust the borders with 1000% spikes, there is one company that currently has 2 of the only 50 licenses to cultivate in Canada, positioning itself to burst out of the gates as new legislation creates a multi-billion-dollar industry over night.
With one of the largest land packages to build cultivation facilities and 2 current licensed facilities located in two provinces in Canada, small-cap Invictus MD (TSX:IMH.V; OTC:IVITF) is set to rise.
It’s already the first licensed medical marijuana company to pay a dividend to shareholders, and with its strains reaching into everything from pain management, cancer, epilepsy, anxiety and – most lucratively of all—recreation, the sky is the limit here.
We’re now just shy of a year away from the start date of legal recreational use, and there are already predictions of a looming supply shortage.
Financial Post reports... there will soon be 3.8 million recreational users... But the market is only currently equipped to handle 150,000 medical marijuana patients.
The industry is scrambling to add growing capacity once the legal barriers are tossed aside.
Deloitte estimates this industry could be worth a whopping $22.6 billion annually. That’s more than the combined sales of beer, wine and spirits.
Right out of the gate, Invictus MD, owner of two of just 50 licenses, has demonstrated that it will lead the way. The company holds $30 million in cash and is already generating dividends—a feat unheard of in the pot industry.
That’s why it’s called ‘Canada’s Cannabis Company’—it’s already cemented market share for medical marijuana use, and now it’s one of the first in and ready to fill the supply gap for a massive recreational push to supply 3.65 million new users.
When you suddenly legalize a product that’s already got a massive market under the table, you mint billionaires overnight. Just like it did at five o’clock on December 5, 1933—the moment Prohibition ended, and a billion-dollar industry (even then) was reborn.
It’s already happening: The shares of the medical marijuana producers more than tripled last year, just at the prospects.
• AXIM Biotechnologies (NASDAQOTH:AXIM): exploded 1,720 percent
• Corbus Pharmaceuticals (NASDAQ:CRBP) was up 431 percent
• Aphria (NASDAQOTH:APHQF) grew 381 percent
• Aurora Cannabis (NASDAQOTH:ACBFF) was up 299 percent
• Canopy Growth Corp. (NASDAQOTH:TWMJF) up 259 percent
• Medical Marijuana (NASDAQOTH:MJNA) up 254 percent
• GW Pharmaceuticals (NASDAQ:GWPH) was up 64 percent
The smart money is investing too. Tribeca Investment Partners, a boutique fund manager, used bets on marijuana companies to help generate a 145 percent return over the year, according to Fortune magazine and Bloomberg. Nearly US$20 million of its investment gains in 2016 came from marijuana stocks, including Aurora Cannabis and Canopy Growth.
Then, in early April, Canada launched its first marijuana exchange-traded fund (ETF), giving investors diverse exposure to this tantalizing sector. The Horizons Medical Marijuana Life Sciences ETF (TSX:HMMJ) launched on the 4th of April on the Toronto Stock Exchange with 11 Canadian-listed stocks and four U.S.-listed stocks.
On 23 June, Invictus was included in the ETF.
The frenzy surrounding Canada’s marijuana market is palpable, and will be even more frenzied on 1 July 2018.
